NEULANDLABBSENEULAND LAB LTD.· PharmaceuticalsLowNeutral
Announced Wed, 28 Oct, 2026 · 12:55 IST

Neuland Labs schedules Q2 FY27 earnings call for November 3

Board & Shareholder Meetings View source PDFExplain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.6%Reaction day
₹19280.00
prior close
₹19840.00
announcement price
In-mkt
timing
Nifty Smallcap 250marketpendingvs market: pending
Pharmaceuticals peers, median of 170sector+0.6%+3.0% vs sector

On the reaction day the stock moved 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.1
15m
-0.1
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.6pendingpending+0.6+3.0
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neuland Laboratories has scheduled its Q2 FY27 earnings call for November 3, 2026 at 17:30 IST, with registration and webcast access. The filing contains no sales, profit, or guidance figures. Neuland says it manufactures APIs for customers in close to 80 countries and has developed over 300 processes and more than 100 APIs.

Likely market impact

The filing is routine and has no direct financial impact. The call may clarify quarterly performance and outlook, so investors should watch management's comments.